Brain cancer fight: new drug combo tested for tough breast cancer cases
NCT ID NCT03765983
Summary
This study tested whether adding an experimental drug called GDC-0084 to the standard treatment Herceptin could help control breast cancer that had spread to the brain. It involved 17 people with a specific type of breast cancer (HER2-positive) that had formed new or growing tumors in the brain. The goal was to see if this combination could shrink these brain tumors and slow the cancer's progression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.